Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Medical Officer
-
Issuer Symbol
-
NGNE on Nasdaq
There are no Buy or Sell transactions made by Julie Jordan since 01 Mar 2025
Holdings reported by Julie Jordan for Neurogene Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
13,300 |
$251,237 |
$18.89 |
20 Feb 2026 |
Direct |
|
|
| Employee Stock Option (Right to buy) |
50,300 |
|
|
26 Mar 2025 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
29,600 |
|
|
20 Feb 2026 |
Direct |
Common Stock |
|
Transactions reported by Julie Jordan for Neurogene Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.